Latest news with #ICRA
Economic Times
12 hours ago
- Business
- Economic Times
Pvt hospitals line up Rs 32k crore capex to add 14.5k beds by FY27: Report
ANI Pvt hospitals line up Rs 32k cr capex to add 14.5k beds by FY27 Eleven listed hospital chains and two major unlisted players are expected to add around 14,500 beds by FY2027, entailing capital expenditure of around Rs 32,000 crore, rating agency ICRA said on Thursday. The industry is projected to maintain strong occupancy levels of 62-64 per cent, record a 6-8 per cent growth in average revenue per occupied bed, and sustain healthy operating profit margins of 22 to 24 per cent, it said. This performance is further supported by structural factors such as increasing market share for organised players, greater insurance penetration, and a rising burden of non-communicable diseases, it added. "Given the strong operating metrics and demand outlook, the industry players have announced sizeable capital expenditure (capex) plans for the medium term. Eleven listed hospital players and two large, unlisted players are cumulatively expected to add around 14,500 beds over FY2026 and FY2027 at a total capex of around Rs 30,000-32,000 crore," ICRA said. This translates to around 26 per cent of their existing bed capacity at the end of FY2025, it added. These bed additions are expected to be across metros, tier-II and tier-III cities, with significant additions in tier-II cities like Nagpur, Lucknow and Coimbatore to cater to the unmet demand in these regions, ICRA said.
Time of India
14 hours ago
- Business
- Time of India
Pvt hospitals line up Rs 32k crore capex to add 14.5k beds by FY27: Report
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel Eleven listed hospital chains and two major unlisted players are expected to add around 14,500 beds by FY2027, entailing capital expenditure of around Rs 32,000 crore, rating agency ICRA said on industry is projected to maintain strong occupancy levels of 62-64 per cent, record a 6-8 per cent growth in average revenue per occupied bed, and sustain healthy operating profit margins of 22 to 24 per cent, it performance is further supported by structural factors such as increasing market share for organised players, greater insurance penetration, and a rising burden of non-communicable diseases , it added."Given the strong operating metrics and demand outlook, the industry players have announced sizeable capital expenditure (capex) plans for the medium term. Eleven listed hospital players and two large, unlisted players are cumulatively expected to add around 14,500 beds over FY2026 and FY2027 at a total capex of around Rs 30,000-32,000 crore," ICRA translates to around 26 per cent of their existing bed capacity at the end of FY2025, it bed additions are expected to be across metros, tier-II and tier-III cities, with significant additions in tier-II cities like Nagpur Lucknow and Coimbatore to cater to the unmet demand in these regions, ICRA said.
Business Standard
17 hours ago
- Business
- Business Standard
ICRA consolidated net profit rises 19.48% in the June 2025 quarter
Sales rise 8.42% to Rs 124.49 croreNet profit of ICRA rose 19.48% to Rs 42.44 crore in the quarter ended June 2025 as against Rs 35.52 crore during the previous quarter ended June 2024. Sales rose 8.42% to Rs 124.49 crore in the quarter ended June 2025 as against Rs 114.82 crore during the previous quarter ended June EndedJun. 2025Jun. 2024% 8 OPM %31.9330.64 -PBDT62.4650.92 23 PBT58.3747.21 24 NP42.4435.52 19 Powered by Capital Market - Live News
News18
17 hours ago
- Business
- News18
ICRA Q1 profit rises 19 pc to Rs 43 cr
Agency: PTI Last Updated: New Delhi, Jul 31 (PTI) Domestic rating agency ICRA on Thursday reported a 19.2 per cent growth in profit at Rs 42.8 crore its June quarter. The firm posted a profit after tax (PAT) of Rs 35.9 crore in the year-ago period. Consolidated revenue from operations increased 8.4 per cent to Rs 124.5 crore for the June quarter compared to Rs 114.8 crore a year earlier. In the current quarter, ICRA has entered into a definitive agreement to acquire 100 per cent shareholding in Fintellix India Pvt Ltd for USD 26 million (Rs 225 crore). The acquisition is subject to the completion of mutually agreed conditions as per the share purchase agreement (SPA). ICRA MD and Group CEO Ramnath Krishnan said, 'Our ratings business continued to benefit from a supportive credit environment, marked by strong bond issuances and securitisation activity. 'The research & analytics segment remained stable, with growth in risk management and market data offset by the residual impact of ESG project discontinuation in the previous year." Given the adverse impact of the escalation in geopolitical conflicts, heightened uncertainty around tariffs, and excess rainfall in May and the second half of June on demand and economic activity, ICRA anticipates India's gross domestic product growth to decelerate to 6.1-6.5 per cent in Q1, FY26 from the high 7.4 per cent in Q4, FY25. We have maintained our GDP growth projection for FY26 at 6.2 per cent, amid expectations of an upbeat outlook for domestic consumption and government capex, even as we remain circumspect around the outcomes for exports and private capex, ICRA said in a statement. PTI JD TRB (This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments First Published: July 31, 2025, 18:30 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
19 hours ago
- Business
- Time of India
Donald Trump's 25% tariff blow hits India: Will your wallet, GDP and global image pay the price? Here's what we know
US President Donald Trump has declared a 25% tariff on goods imported from India, starting August 1, with an added but unspecified penalty. The action, announced on his Truth Social platform, ties India's trade to its continued imports of Russian oil and arms. Trump wrote that India is buying from Russia 'at a time when everyone wants Russia to STOP THE KILLING IN UKRAINE.' The magnitude of the economic impact will depend heavily on details still to come. Experts suggest that if the additional penalty is steep, it could further reduce India's growth prospects. Growth forecasts lowered as markets react Ratings agency ICRA has adjusted its GDP projection for India from 6.5% to 6.2%, citing the tariff hike. Chief Economist Aditi Nayar said the measures are more severe than expected and will likely pose a challenge to growth. Nomura added that the decision is 'growth negative' and could shave 0.2% off GDP. Donald Trump has just imposed a 25% tariff on India. He has also imposed a penalty. ⦁ Modi campaigns for Trump.⦁ Gives out slogans like 'Abki Baar Trump Sarkar'. ⦁ Hugs him like a long-lost return, Trump goes on to impose such harsh tariff on India. It is… Markets responded with caution. Indian indices opened in the red following the announcement. Fund manager Nilesh Shah noted that the markets had anticipated a trade deal, given broader alignment in US-India strategic interests. Export competitiveness at risk India had reduced tariffs on goods like Bourbon whiskey and motorcycles to encourage a deal, but the US continues to run a $45 billion trade deficit with India. Trump has prioritized closing that gap. Compared to China and Vietnam — who recently negotiated lower US tariffs — India now appears less competitive. Rahul Ahluwalia from the Foundation for Economic Development said the tariff structure leaves India disadvantaged in competing for foreign investments and manufacturing. The likely sectors to face an immediate impact are marine products, automobiles, pharmaceuticals, leather, and textiles, according to Agneshwar Sen of EY India. Donald Trump impose 25% tariffs on India 😡Trump Put India and China in same category 🤔Miss You Biden 🤣#viralvideo #DonaldTrump #tariff #pmmodi #china Exporters caught in the middle Indian exporters may need to renegotiate pricing with US buyers. Dr. Ajay Sahai, who leads a federation of export organizations, said the tariffs will result in price adjustments and affect margins, particularly where exporters are forced to absorb some of the hike to stay competitive. India's commerce ministry said it is reviewing the implications of the move. It emphasized a commitment to reaching a mutually beneficial deal but reiterated the importance of protecting vulnerable sectors like agriculture and small businesses. Political and strategic fallout India's opposition Congress party criticized Prime Minister Modi for his earlier public support of Trump, calling the tariff announcement a 'catastrophic failure of foreign policy.' Trump's decision to connect the trade penalty with India's economic ties to Russia has further complicated the ongoing negotiations. Mark Linscott, former US trade representative, noted that incorporating defense and energy into trade discussions has made reaching an agreement more difficult. Despite the current tensions, both sides appear committed to continuing talks. The US is India's top export destination, and the two countries conduct $190 billion in bilateral trade — a figure they hope to grow to $500 billion. Still, even under the best-case scenario, tariff rates might settle at 15–20%, which Nomura said is underwhelming considering India's progress in earlier rounds of talks. Outlook: Uncertain but ongoing While India's economy is less dependent on goods exports than some of its Asian counterparts, analysts believe the tariff issue could influence monetary policy decisions. Nomura suggested that the pressure on growth might encourage India's central bank to consider further rate cuts to maintain momentum. Trump's tariff move could disrupt India's exports and growth path unless negotiations reset the balance in time. To stay updated on the stories that are going viral follow Indiatimes Trending.
